ANI Pharmaceuticals | ANIP - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.59B 180M 2025-12
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Assertio Holdings USD 39.91M 2.7M 2024-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Canopy Growth CAD 140.42M 113.56M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Omeros USD 8.08M 440K 2024-06
Perrigo USD 697.1M 84.3M 2026-03
Sun Pharmaceuticals INR 157.04B 26.1B 2025-09
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03